What Happens in the Room Where Biopharma Deals Happen

Overview

In this episode, Devang Bhuva, Senior Vice President, Corporate Development and Alliance Management at Gilead speaks with Yaron Werber, M.D., Biotechnology Analyst. They share an inside look at the deal-making process from start to finish. They discuss how deals get done, trends in oncology M&A, the framework that potential acquirers use to triage and identify potential targets, and what happens on both sides of the negotiating table.

Listen to the Podcast here.

Contact

Tobias
Levedag

Partner
M&A, Cowen

+49 89 2000 393 70
Email

Headshot DB

Dierk
Beyer

Partner
M&A, Cowen

+49 69 5060 675 62
Email

Similar Insights

Image Pharma Services Report May 22
Pharma Services Report April
Insights Cowen Valued-Based Care Health Care Business Model Transformation